Trial Profile
Investigation of the safety and efficacy of Epolyrec on ESRD patients on hemodialysis and comparison with EPREX
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Mar 2018
Price :
$35
*
At a glance
- Drugs Erythropoietin (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Sponsors Notarkib Recpharma Biopharmaceuticals
- 22 Feb 2018 Status changed from recruiting to completed.
- 19 May 2015 New trial record